PF-04856884 (CVX-060) In Combination With Axitinib In Patients With Previously Treated Metastatic Renal Cell Carcinoma

Clinical trial NCT01441414 · TERMINATED

Trial details

NCT number: NCT01441414
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Renal Cell Carcinoma

Start date: 2011-11-21
Primary completion: 2014-03-27
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.